Velonivex represents a groundbreaking innovation in the realm of oncology. This novel therapeutic agent operates on a unprecedented mechanism, targeting mutated proteins that are essential to cancer growth. Unlike traditional treatments, Velonivex aims to destroy cancer cells while reducing harm to surrounding structures. Clinical trials have shown